Article
Identification of IGF2BP2 as a Prognostic Biomarker and Immunotherapeutic Target Based on Alternative Splicing Events in Glioblastoma
2021-09-21
Abstract excerpt
<title>Abstract</title> <p><bold>Aim:</bold> A glioblastoma (GBM) prognostic model was developed with GBM -related alternative splicing (AS) data and prognostic markers were identified. <bold>Methods:</bold> AS data and clinical data of GBM patients were retrieved from The Cancer Genome Atlas (TCGA) SpliceSeq database and TCGA database, respectively. The data from these two databases were intersected to screen th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 45f48a3b-917c-5242-8908-cf6b0168bd1e
- DOI
- 10.21203/rs.3.rs-900457/v1
